GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Other Stockholders Equity

PolyPeptide Group AG (XSWX:PPGN) Other Stockholders Equity : CHF21.7 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Other Stockholders Equity?

PolyPeptide Group AG's Other Stockholders Equity for the quarter that ended in Dec. 2023 was CHF21.7 Mil.

PolyPeptide Group AG's quarterly Other Stockholders Equity declined from Dec. 2022 (CHF17.5 Mil) to Jun. 2023 (CHF10.8 Mil) but then increased from Jun. 2023 (CHF10.8 Mil) to Dec. 2023 (CHF21.7 Mil).

PolyPeptide Group AG's annual Other Stockholders Equity increased from Dec. 2021 (CHF13.8 Mil) to Dec. 2022 (CHF17.5 Mil) and increased from Dec. 2022 (CHF17.5 Mil) to Dec. 2023 (CHF21.7 Mil).


PolyPeptide Group AG Other Stockholders Equity Historical Data

The historical data trend for PolyPeptide Group AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Other Stockholders Equity Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial -2.94 -6.07 13.77 17.48 21.74

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.77 23.46 17.48 10.78 21.74

PolyPeptide Group AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


PolyPeptide Group AG Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


PolyPeptide Group AG (XSWX:PPGN) Business Description

Traded in Other Exchanges
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines